[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1962

Production and Control of Measles Vaccine in the U.S.S.R.

Author Affiliations

MOSCOW, U.S.S.R.
V. M. Zhdanov, Institute of Virology, Moscow, U.S.S.R.; Institute of Virology, Moscow.

Am J Dis Child. 1962;103(3):502-505. doi:10.1001/archpedi.1962.02080020514072
Abstract

The development of stable cultures of measles virus, which has lost its pathogenic characters for human beings, is a necessary prerequisite for active immunization against measles with the live vaccine.

There are 3 directions in the investigations on the creation of attenuated strains for the live vaccines:

  1. The adaptation of a measles virus to different species of animals: rabbits, mice, whelp of dogs, monkeys, and suckling pigs.1-4

  2. The adaptation of a measles virus to chick embryos.5,6

  3. The adaptation of a measles virus to cultures of different tissue systems of animals and man, prepared as explants of monolayer cultures.7-11

We have produced an attenuated strain by propagating measles virus, strain USSR-58, isolated in Moscow in 1958, from the blood of measles cases and in parallel studies carried out with cultures of trypsinized tissues of human amnion (HuATC), monkey kidney (MK), or fibroblasts of chick embryos (FEg) in the

First Page Preview View Large
First page PDF preview
First page PDF preview
×